Usted buscó: chlorzoxazone (Inglés - Maltés)

chlorzoxazone*
chlorzoxazone*

influence of enfuvirtide on metabolism of concomitant medicinal products: in an in-vivo human metabolism study enfuvirtide, at the recommended dose of 90 mg twice daily, did not inhibit the metabolism of substrates by cyp3a4 (dapsone), cyp2d6 (debrisoquine), cyp1a2 (caffeine), cyp2c19 (mephenytoin), and cyp2e1 (chlorzoxazone).
l-effett ta’ enfuvirtide fuq il-metaboliżmu ta’ prodotti mediċinali li jingħataw fl-istess ħin: fi studju in vivo tal-metaboliżmu uman, enfuvirtide, fid-doża rakkomandata ta’ 90 mg darbtejn kuljum, ma waqqafx il-metaboliżmu ta’ substrati permezz ta’ cyp3a4 (dapsone), cyp2d6 (debrisoquine), cyp1a2 (kaffeina), cyp2c19 (mephenytoin), u cyp2e1 (chlorzoxazone).